Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
5.31 USD | +0.38% | +8.15% | -18.18% |
Kurzporträt
Mitarbeiterzahl: 66
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Amy Burroughs
CEO | Chief Executive Officer | 53 | 07.02. |
Erin Quirk
PSD | President | 53 | 01.01.19 |
Mark Vignola
DFI | Director of Finance/CFO | 46 | 11.08.20 |
Bryan Yoon
COO | Chief Operating Officer | 47 | 01.11.20 |
Chief Tech/Sci/R&D Officer | - | 06.01.22 | |
Justin Ng
IRC | Investor Relations Contact | - | - |
Corporate Officer/Principal | 44 | 01.05.23 | |
Melita Sun Jung
PRN | Corporate Officer/Principal | 46 | 22.04. |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
David Fellows
CHM | Chairman | 67 | 01.12.20 |
Jeffrey Kindler
BRD | Director/Board Member | 68 | 01.12.20 |
Carl Gordon
BRD | Director/Board Member | 59 | 01.10.18 |
Hong Bo Lu
BRD | Director/Board Member | 53 | 01.04.20 |
Director/Board Member | 44 | 26.07.22 | |
Jill Quigley
BRD | Director/Board Member | 48 | 01.12.20 |
Amy Burroughs
CEO | Chief Executive Officer | 53 | 07.02. |
Erin Quirk
PSD | President | 53 | 01.01.19 |
Ann Taylor
BRD | Director/Board Member | - | 28.09.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 64 674 780 | 62 397 905 ( 96,48 %) | 0 | 96,48 % |
Unternehmenskontakt
Terns Pharmaceuticals, Inc.
1065 East Hillsdale Boulevard Suite 100
94404, Foster City
+650 525 5535
http://www.ternspharma.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-18.18% | 342 Mio. | |
+24.64% | 48.09 Mrd. | |
+46.90% | 40.62 Mrd. | |
-3.17% | 40.43 Mrd. | |
-6.20% | 28.36 Mrd. | |
+9.39% | 24.89 Mrd. | |
-20.36% | 19.01 Mrd. | |
+28.59% | 12.09 Mrd. | |
+0.64% | 11.88 Mrd. | |
-1.21% | 11.8 Mrd. |
- Börse
- Aktien
- A2QNWR Aktie
- Unternehmen Terns Pharmaceuticals, Inc.